A recombinant 31.5 kDa keratinase and a crude exo-antigen from Microsporum canis fail to protect against a homologous experimental infection in guinea pigs

Veterinary Dermatology

Volumn 14, Issue 6, 2003, Pages 305-312

  Descamps, Frédéric F ^a   Brouta, Frédéric ^b   Vermout, Sandy M ^a   Willame, Corinne ^a   Losson, Bertrand J ^a   Mignon, Bernard R ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UCB   (Belgium)

Author keywords

Dermatophyte; Keratinase; Microsporum canis; Subtilisin like serine protease; Vaccine

Indexed keywords

FUNGUS ANTIGEN; KERATINASE; RECOMBINANT ENZYME;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; DERMATOMYCOSIS; EVALUATION; GUINEA PIG; HUMORAL IMMUNITY; IMMUNE RESPONSE; MICROSPORUM CANIS; NONHUMAN; PROTECTION; VACCINATION;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; DERMATOMYCOSES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL VACCINES; GUINEA PIGS; MICROSPORUM; PEPTIDE HYDROLASES; RANDOM ALLOCATION;

ANIMALIA; CANIS; CAVIA; CAVIA PORCELLUS; FUNGI; MICROSPORUM; MICROSPORUM CANIS; SUS SCROFA;

EID: 0348230704     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2003.00342.x     Document Type: Article

References (48)

1. Scott, D.W., Miller, W.H., Griffin, C.E. Fungal skin diseases. Muller and Kirk's Small Animal Dermatology. W.B. Saunders Co., Philadelphia, 2001: 339-61.
2. Moriello, K.A. Management of dermatophyte infections in catteries and multiple-cat households. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 1457-74.
3. Moriello, K.A., DeBoer, D.J. Feline dermatophytosis. Recent advances and recommendations for therapy. Veterinary Clinics of North America: Small Animal Practice 1995; 25: 901-21.
4. Hnilica, K.A., Medleau, L. Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. Veterinary Dermatology 2002; 13: 23-8.
5. Moriello, K.A., DeBoer, D.J. Efficacy of griseofulvin and itraconazole in the treatment of experimentally induced dermatophytosis in cats. Journal of the American Veterinary Medical Association 1995; 207: 439-44.
6. Ben-Ziony, Y., Arzi, B. Use of lufenuron for treating fungal infections of dogs and cats. Journal of the American Veterinary Medical Association 2000; 217: 1510-13.
7. Guillot, J., Malandain, E., Jankowski, F. et al. Evaluation of the efficacy of oral lufenuron combined with topical enilconazole for the management of dermatophytosis in catteries. Veterinary Record 2002; 150: 718-24.
8. Sparkes, A.H., Werrett, G., Stokes, C.R. et al. Microsporum canis. Inapparent carriage by the cats and the viability of arthrospores. Journal of Small Animal Practice 1994; 35: 397-401.
9. Lunder, M., Lunder, M. Is Microsporum canis infection about to become a serious dermatological problem? Dermatology 1992; 184: 87-9.
10. Mignon, B., Losson, B. Prevalence and characterization of Microsporum canis carriage in cats. Journal of Medical and Veterinary Mycology 1997; 35: 249-56.
11. Symoens, F., Fauvel, E., Nolard, N. Evolution de la contamination de l'air et des surfaces par Microsporum canis dans une habitation. Bulletin de la Société Française de Mycologie Médicale 1989; 18: 293-8.
12. DeBoer, D.J., Moriello, K.A. The immune response to Microsporum canis induced by a fungal cell wall vaccine. Veterinary Dermatology 1994; 5: 47-55.
13. DeBoer, D.J., Moriello, K.A. Investigations of a killed dermatophyte cell wall vaccine against infection with Microsporum canis in cats. Research in Veterinary Sciences 1995; 59: 110-13.
14. DeBoer, D.J., Moriello, K.A., Blum, J.L. et al. Safety and immunologic effects after inoculation of inactivated and combined live-inactivated dermatophytosis vaccines in cats. American Journal of Veterinary Research 2002; 63: 1532-7.
15. Mignon, B., Swinnen, M., Bouchara, J.P., et al. Purification and characterization of a 31.5 kDa keratinolytic subtilisin-like serine protease from Microsporum canis and evidence of its secretion in naturally infected cats. Medical Mycology 1998; 36: 395-404.
16. Descamps, F., Brouta, F., Monod, M. et al. Isolation of a Microsporum canis gene family encoding three subtilisin-like proteases expressed in vivo. Journal of Investigative Dermatology 2002; 119: 830-5.
17. Mignon, B., Leclipteux, T., Focant, C. et al. Humoral and cellular immune response to a crude exo-antigen and purified keratinase of Microsporum canis in experimentally infected guinea pigs. Medical Mycology 1999; 37: 123-9.
18. Calderon, R.A., Hay, R.J. Cell-mediated immunity in experimental murine dermatophytosis II. Adoptive transfer of immunity to dermatophyte infection by lymphoid cells from donors with acute or chronic infections. Immunology 1984; 53: 465-72.
19. Sohnle, P.G. Dermatophytoses. In: Cox, R.A., ed. Immunology of Fungal Diseases. CRC Press, Boca Raton, FL, 1989: 1-27.
20. Descamps, F., Brouta, F., Vermout, S. et al. Recombinant expression and antigenic properties of a 31.5 kDa keratinolytic subtilisin-like serine protease from Microsporum canis. FEMS Immunology and Medical Microbiology (in press).
21. Brouta, F., Descamps, F., Fett, T. et al. Purification and characterization of a 43.5 kDa keratinolytic metalloprotease from Microsporum canis. Medical Mycology 2001; 39: 269-75.
22. Mignon, B.R., Coignoul, F., Leclipteux, T. et al. Histopathological pattern and humoral immune response to a crude exo-antigen and purified keratinase of Microsporum canis in symptomatic and asymptomatic infected cats. Medical Mycology 1999; 37: 1-9.
23. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248-54.
24. Van Cutsem, J. Animal models for dermatomycotic infections. In: McGinnis, M.R., Borgers, M., eds. Current Topics in Medical Mycology, Vol. 3. Springer, New York, 1989: 1-35.
25. Kristensen, F., Kristensen, B., Lazary, S. The lymphocyte stimulation test in veterinary immunology. Veterinary Immunology and Immunopathology 1982; 3: 203-77.
26. Grappel, S.F., Bishop, C.T., Blank, F. Immunology of dermatophytes and dermatophytosis. Bacteriological Reviews 1974; 38: 840-8.
27. Jones, H.E., Reinhardt, J.H., Rinaldi, M.G. Acquired immunity to dermatophytes. Archives of Dermatology 1974; 109: 840-8.
28. Pier, A.C., Hodges, A.B., Lauze, J.M. et al. Experimental immunity to Microsporum canis and cross reactions with other dermatophytes of veterinary importance. Journal of Medical and Veterinary Mycology 1995; 33: 93-7.
29. Wawrzkiewicz, K., Ziolkowska, G. Specific immunoprophylaxis in Microsporum canis infection in guinea pigs. Journal de Mycologie Médicale 1996; 6: 56-62.
30. Calderon, R.A., Shennan, G.I. Susceptibility of Trichophyton quinckeanum and Trichophyton rubrum to products of oxidative metabolism. Immunology 1987; 61: 283-8.
31. Sparkes, A.H., Stokes, C.R., Gruffydd-Jones, T.J. Experimental Microsporum canis infection in cats: correlation between immunological and clinical observations. Journal of Medical and Veterinary Mycology 1995; 33: 177-84.
32. Brouta, F., Descamps, F., Vermout, S. et al. Secreted metalloproteases of Microsporum canis. Infection and Immunity 2002; 70: 5676-83.
33. Grappel, S.F., Blank, F. Role of keratinases in dermatophytosis. I. Immune responses of guinea pigs infected with Trichophyton mentagrophytes and guinea pigs immunized with keratinases. Dermatologica 1972; 145: 245-55.
34. Mosher, C.L., Langendoen, K., Stoddard, P. Treatment of ringworm (Microsporum canis) with inactivated fungal vaccine. Veterinary Medicine/Small Animal Clinician 1977; 72: 1343-5.
35. Hussin, Z., Smith, J.M.B. Vaccination procedures and the infectivity of dermatophyte lesions. Mycopathologia 1983; 81: 71-6.
36. Wharton, M.L., Reiss, F., Wharton, D.R.A. Active immunization against Trichophyton purpureum infection in rabbits. Journal of Investigative Dermatology 1950; 14: 291-303.
37. Reiss, F., Leonard, L. Failure of active immunization against Trichophyton gypseum infection in guinea pigs. Journal of Investigative Dermatology 1956; 26: 449-52.
38. Elad, D., Segal, E. Immunogenicity in guinea pigs of a crude ribosomal fraction from Microsporum canis. Vaccine 1994; 12: 134-8.
39. Dreesen, D.W., Summer, J.W., Brown, J. et al. Intradermal use of human diploid cell vaccine for pre-exposure rabies immunization. Journal of the American Veterinary Medical Association 1982; 181: 1519-23.
40. Rybnikar, A., Vrzal, V., Chumela, J. Protective efficacy of vaccine against bovine trichophytosis after intramuscular, subcutaneous, and intradermal administration. Acta Veterinaria Brno 1997; 66: 57-60.
41. Mignon, B., Losson, B. Vaccination against ringworm in cattle. In: Pastoret, P.-P., Blancou, J., Vannier, P., Verschueren, C., eds. Veterinary Vaccinology. Elsevier Science BV, Amsterdam, 1997: 490-1.
42. Grun, J.L., Maurer, P.H. Different T-helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cellular Immunology 1989; 121: 134-45.
43. Bretscher, P.A. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunology Today 1992; 13: 342-5.
44. Zuckermann, F.A., Martin, S., Husmann, R.J. et al. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Advances in Veterinary Medicine 1999; 41: 447-61.
45. Gudding, R., Naess, B. Vaccination of cattle against ringworm caused by Trichophyton verrucosum. American Journal of Veterinary Research 1986; 47: 2415-17.
46. Pier, A.C., Zancanella, P.J. Immunization of horses against dermatophytosis caused by Trichophyton equinum. Equine Practice 1993; 15: 23-7.
47. MacEnzie, D.W.R., Loeffler, W. et al. Guidelines for the Diagnosis, Prevention and Control of Dermatophytoses in Man and Animals World Health Organization, Geneva, 1986: 55-68.
48. Pier, A.C., Smith, J.M.B., Alexiou, H. et al. Animal ringworm - its aetiology, public health significance and control. Journal of Medical and Veterinary Mycology 1994; 32 (Suppl. 1): 133-50.